Psychomotor Agitation: Clinical Trials

48 trials for Psychomotor Agitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 8 unknown, 5 withdrawn, 1 not yet recruiting. 48 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 448Completed 33, Unknown 8, Withdrawn 5, Not yet recruiting 1, Terminated 1

Follow Psychomotor Agitation: new trials by email Literature Review of Psychomotor Agitation trials Research Report on Psychomotor Agitation

Trials (filtered) newest first · largest first

All 48 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Esketamine - Dexmedetomidine Combination Versus Dexmedetomidine Monotherapy for Hyperactive Delirium in ICU Patients on Non-Invasive Respiratory Support (SEED-NIRS Trial): Study Protocol of a Randomized Controlled Trial
Esketamine combined with dexmedetomidine, Dexmedetomidine - Dexmedetomidine, Ketamine
Phase 4Not yet recruitingThe First Affiliated Hospital with Nanjing Medical University3562026-09-282026-09-03
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia
Phase 4CompletedBioXcel Therapeutics Inc292023-10-022026-08-11
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Sublingual film containing dexmedetomidine (BXCL501) - Agitation, Schizophrenia
Phase 4WithdrawnBrigham and Women's Hospital2023-09-012026-01-28
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder
Phase 4UnknownTemple University322023-07-012023-10-23
Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics
Nalbuphine, Dexmedetomidine, normal Saline - Agitation
Phase 4UnknownAlexandria University1262022-03-012022-04-08
Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine
Mirtazapine, Melatonin, Placebo - Agitation
Phase 4CompletedAin Shams University1652021-06-152022-04-15
Dexmedetomidine Combined With Hydromorphone in Tonsillectomy and Adenoidectomy
Dexmedetomidine 0.5μg/kg, Dexmedetomidine 1μg/kg - Agitated; State, Acute Reaction to Stress
Phase 4CompletedEye & ENT Hospital of Fudan University1302019-01-042021-06-22
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
Haloperidol + Promethazine + Chlorpromazine, Haloperidol + Promethazine - Psychiatric Emergency, Aggression
Phase 4CompletedJoseph Dib1002018-08-282022-06-14
Does Low Flow Anesthesia Reduce Postanaesthetic Emergence Agitation?
Analgesics, Antiemetics - Agitated; State, Acute Reaction to Stress
Phase 4CompletedSakarya University602018-06-012020-03-18
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
Haloperidol + lorazepam, Loxapine - Agitation,Psychomotor, Haloperidol Causing Adverse Effects in Therapeutic Use
Phase 4TerminatedUniversity of Arkansas22017-09-302018-06-11
Gabapentin as Preanesthetic Medication to Fast Procedures in Pediatric´s Oncology
Placebo Group, GABA 15mg/kg Group, GABA 30mg/kg Group - Pain, Postoperative, Agitation States as Acute Reaction to Exceptional Stress
Phase 4CompletedHospital Infantil Albert Sabin1352017-07-012018-09-27
The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation
Magnesium Sulfate, Normal saline - Agitation,Psychomotor
Phase 4CompletedSeoul National University Bundang Hospital922017-03-192023-09-11
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation
Ziprasidone - Schizophrenia
Phase 4UnknownYang Fude10002016-10-012016-10-18
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting
Staccato® Delivery System Loxapine (ADASUVE®) - Agitation
Phase 4CompletedFerrer Internacional S.A.3232016-09-082020-11-04
Comparison of Ketamine-propofol Combinations
Ketamine-propofol mixture - Agitation, Postoperative Pain
Phase 4CompletedCukurova University752016-07-012017-04-20
Scalp Nerve Block on Emergence Agitation
Ropivacaine, Remifentanil, Sevoflurane - Agitation
Phase 4CompletedAjou University School of Medicine442015-05-012017-01-25
Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward
Ketamine - Psychomotor Agitation, Psychiatric Disorder
Phase 4CompletedUniversidad Nacional de Rosario5002015-01-012017-07-13
Does Intraoperative Clonidine Reduce Post Operative Agitation in Children?
Clonidine, Placebo - Psychomotor Agitation
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet3792015-01-012019-02-11
Study of Sedative Medications in Patients With Severe Infection and Respiratory Failure
Propofol, Dexmedetomidine, Fentanyl - Sepsis, Respiratory Failure
Phase 4CompletedTexas Tech University Health Sciences Center362014-08-012020-03-02
Small Doses of Dexmedetomidine for Emergence Agitation
Sevoflurane, Dexmedetomidine, Placebo(for Dexmedetomidine) - Emergence Agitation
Phase 4UnknownTang-Du Hospital802014-05-012014-06-23

Showing 20 of 48. Sign in to see all of them.

Narrower conditions

Psychotic Disorders (11)  ·  Alzheimer Disease (7)  ·  Dementia (6)  ·  Schizophrenia (6)  ·  Aggression (4)  ·  Bipolar Disorder (4)  ·  Delirium (4)  ·  Mental Disorders (2)  ·  Nausea (2)  ·  Pain (2)  ·  Pain, Postoperative (2)  ·  Stress Disorders, Traumatic, Acute (2)  ·  Acute Disease (1)  ·  Agnosia (1)

Broader conditions

Aberrant Motor Behavior in Dementia (48)  ·  Behavioral Symptoms (48)  ·  Dyskinesias (48)  ·  Nervous System Diseases (48)  ·  Neurobehavioral Manifestations (48)  ·  Neurologic Manifestations (48)  ·  Pathological Conditions, Signs and Symptoms (48)  ·  Psychomotor Disorders (48)  ·  Signs and Symptoms (48)  ·  Behavior (47)  ·  Mental Disorders (22)  ·  Neurocognitive Disorders (14)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (13)  ·  Brain Diseases (10)  ·  Central Nervous System Diseases (10)

Interventions

Dexmedetomidine (13)  ·  Haloperidol (6)  ·  Saline Solution (6)  ·  Risperidone (5)  ·  Quetiapine Fumarate (4)  ·  Lorazepam (3)  ·  Sodium Chloride (3)  ·  Diphenhydramine (2)  ·  Escitalopram (2)  ·  Ketamine (2)  ·  Loxapine (2)  ·  Magnesium Sulfate (2)  ·  Memantine (2)  ·  Metoclopramide (2)  ·  Olanzapine (2)

Sponsors

Ain Shams University (2)  ·  New York State Psychiatric Institute (2)  ·  Seoul National University Hospital (2)  ·  Abarbanel Mental Health Center (1)  ·  Ajou University School of Medicine (1)  ·  Alexandria University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  BioXcel Therapeutics Inc (1)  ·  Brigham and Women's Hospital (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Cukurova University (1)  ·  Diskapi Yildirim Beyazit Education and Research Hospital (1)  ·  East Kent Hospitals University NHS Foundation Trust (1)  ·  Emory University (1)  ·  Eye & ENT Hospital of Fudan University (1)

Countries

United States (18)  ·  China (5)  ·  South Korea (5)  ·  Egypt (3)  ·  Turkey (Türkiye) (3)  ·  Argentina (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Israel (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  Spain (1)

Top investigators

Adrian Leibovici MD (1)  ·  AhYoung Oh (1)  ·  Alaa Elkateb, MD (1)  ·  Ali Fuat Erdem, Professor (1)  ·  Andrea Snow, PhD MS BS (1)  ·  Ben Jong,de, MD (1)  ·  Benjamin W Friedman, MD (1)  ·  BioXcel MM, MD (1)  ·  Brian Daley (1)  ·  Brooke Bender, MD (1)  ·  Davangere Devanand, M.D. (1)  ·  Davangere P. Devanand, MD (1)  ·  David Frey, MD (1)  ·  Didier Dreyfuss, MD (1)

Results publications

PMID 11442853, PMID 16247923, PMID 20418301, PMID 20705788, PMID 21476613, PMID 21845596, PMID 22567095, PMID 23075176, PMID 23422376, PMID 24606117, PMID 25230144, PMID 26332857, PMID 27264945, PMID 27855483, PMID 28877705, PMID 29249041, PMID 29881956, PMID 30169192, PMID 30282677, PMID 32528650, PMID 34627829

NIH funding

2005 (1), 2009 (1), R01AG021488 (1), R01MH055735 (1)